ARCHIVES

US Oncology Begins Trial Of Taxotere And Xeloda

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

October 1, 1993

Health Association Oppose U.S. Trade Policy On Tobacco Exports; Recommend Restrictions

August 25, 1989

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

NCI Bypass Budget For FY 1992 Requests $2.6 Billion Support grows In Congress

May 18, 1990